We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Gastroenterology

Peripheral Parenteral Nutrition Reduces Inflammation and Enhances Nutritional Recovery After Colorectal Surgery: Insights from a Randomized Trial

MedXY Editorial Team•Oct 5, 2026•Gastroenterology
Colorectal SurgeryinflammationNitrogen BalancePeripheral Parenteral Nutrition

Highlight

  • Peripheral parenteral nutrition (PPN) after colorectal surgery reduces early postoperative inflammatory response as measured by procalcitonin levels.
  • PPN improves short-term nitrogen balance, indicating a mitigation of postoperative catabolism compared to standard dextrose-saline infusion.
  • The use of PPN is safe with no significant increase in overall or major postoperative complications.

Study Background

Major colorectal surgery induces significant metabolic stress and an inflammatory response, leading to postoperative catabolism and delayed functional recovery. These physiological perturbations impair protein synthesis and increase muscle breakdown, adversely affecting wound healing, immune competence, and overall recovery trajectory. Nutritional support in the early postoperative period is crucial to counteract these effects; however, the optimal mode and timing of nutritional intervention remain under investigation. Peripheral parenteral nutrition offers a minimally invasive method to deliver essential macronutrients postoperatively but lacks robust clinical trial evidence in colorectal surgery populations. This study addresses this gap by evaluating whether early postoperative peripheral parenteral nutrition modulates inflammatory markers and improves short-term nutritional status in patients undergoing colorectal resection.

Study Design

This was an open-label, randomized controlled superiority trial (NCT06737211) conducted among adult patients undergoing either elective or emergency colorectal resection. Participants were randomized 1:1 to receive either peripheral parenteral nutrition (PPN) or 5% dextrose-normal saline with identical electrolyte supplementation over the first five postoperative days. The PPN regimen included macronutrients appropriate for nutritional repletion delivered via peripheral venous access. The primary endpoints included postoperative complications assessed by the Clavien-Dindo classification, inflammatory markers such as procalcitonin levels, and nutritional parameters including nitrogen balance. A modified intention-to-treat analysis was employed to preserve the integrity of randomization while accounting for protocol deviations.

Key Findings

A total of 207 patients were analyzed, with 103 in the PPN arm and 104 in the control group. Baseline demographic and operative characteristics were well matched, mitigating selection bias. Postoperative complication rates did not differ significantly between the groups: 35% in the PPN group versus 42.3% in controls (P = .278), and major complications (Clavien-Dindo ≥3) were also similar (25% vs 28.9%, P = .696), supporting the safety of PPN.

Inflammatory response, assessed via procalcitonin—a biomarker reflecting systemic inflammation and bacterial infection—was significantly attenuated in the PPN group. On postoperative day 3, patients receiving dextrose-saline had a 69% higher median procalcitonin level than those receiving PPN (ratio of medians 1.69; 95% CI, 1.15-2.49; P = .008), suggesting a moderated inflammatory milieu with nutritional support.

From a nutritional standpoint, nitrogen balance, an index of protein metabolism reflecting net body protein gain or loss, was significantly more favorable in the PPN group. The beta coefficient of -5.6 (95% CI, -7.9 to -3.3; P < .001) indicated that patients in the control group experienced a more negative nitrogen balance, thus greater catabolism, compared to those receiving PPN. This improved nitrogen retention in the PPN arm translates into better preservation of lean body mass and potentially improved recovery.

These biochemical and nutritional advantages did not translate into a higher complication rate or adverse safety signal, highlighting PPN as a well-tolerated intervention.

Expert Commentary

This study provides compelling evidence to support the adoption of early peripheral parenteral nutrition after colorectal resection. The attenuation of procalcitonin suggests that targeted nutritional supplementation may modulate systemic inflammatory responses, potentially via reduced metabolic stress and immune support mechanisms. Improved nitrogen balance aligns with preclinical models demonstrating that adequate protein supply prevents muscle wasting and supports anabolism.

However, limitations include the open-label design, which could introduce performance bias, although objective biomarkers were primary outcomes. The trial’s single-center nature may affect generalizability, and long-term outcomes such as functional recovery and quality of life were not assessed. Further multicentric studies incorporating functional metrics and cost-effectiveness analyses could strengthen evidence for routine clinical implementation.

Clinicians should also consider patient-specific factors such as baseline nutritional status, comorbidities, and risk of parenteral nutrition-associated complications when tailoring postoperative care.

Conclusion

Early postoperative peripheral parenteral nutrition following colorectal resection surgery is a safe and effective strategy to attenuate systemic inflammation and improve nitrogen balance, key determinants of postoperative recovery. The intervention does not increase postoperative complications and may facilitate a more favorable metabolic milieu conducive to healing and functional restoration. This trial underscores the importance of nutritional interventions as adjunctive therapies in major abdominal surgery and prompts further research into optimizing perioperative nutrition protocols.

Funding and ClinicalTrials.gov

The trial was registered on ClinicalTrials.gov (NCT06737211). Details on funding were not specified in the abstract. Further inquiry into funding sources and potential conflicts of interest is advisable to assess study independence.

References

Frountzas M, Mela E, Stefanoudakis D, Theodorou P, Gkotsi I, Linardoutsos D, Triantafyllou T, Chamzin A, Manouras I, Smparounis S, Memos N, Theodorou D, Theodoropoulos G, Toutouzas K. Peripheral parenteral nutrition improves short-term nutritional status and inflammatory reaction after colorectal resection surgery: A randomized clinical trial. Surgery. 2026 Jul 18;198:110458. doi:10.1016/j.surg.2026.110458. PMID: 42561639.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Unraveling Abdominal Aortic Aneurysm: Epigenetic Links to Inflammation and Lipid MetabolismAn epigenome-wide study reveals that DNA methylation markers linked to inflammatory pathways and blood lipid traits play a causal role in abdominal aortic aneurysm development, offering potential for improved risk prediction and therapeuticOct 3, 2026Impact of Germline and Somatic DNMT3A Variants on Pulmonary Arterial Hypertension: A New Frontier in Biomarkers and TherapeuticsGermline and somatic variants in DNMT3A and other CHIP genes elevate pulmonary arterial hypertension risk, including connective tissue disease-associated forms, through pro-inflammatory pathways, highlighting novel biomarkers and therapeutiSep 8, 2026TP53-Mutated Clonal Hematopoiesis Drives Pro-Inflammatory Phenotype and Predicts Poor Outcomes After CAR T-Cell TherapyTP53-mutant clonal hematopoiesis in CAR T-cell recipients is linked to a pro-inflammatory state, cytopenias, and worse survival, highlighting the importance of tailored monitoring strategies in this high-risk group.Aug 26, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing &amp; care
How often should a couple have sex?
Cardiology
Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Transforming Readmission Risk After Colorectal Surgery in Older Adults: From Nonmodifiable to Actionable Geriatric and Comorbidity Factors
This study highlights that geriatric vulnerabilities and comorbidities, once considered nonmodifiable, play a dominant role in 30-day readmissions after colorectal surgery in older adults, emphasizing the need for integrated perioperative i
Aug 25, 2026
Semaglutide’s Impact on Inflammation and Cardiovascular Risk in Overweight Patients: Insights from the SELECT TrialIn the SELECT trial, semaglutide significantly lowered hsCRP levels and major cardiovascular events in patients with established atherosclerotic cardiovascular disease and overweight or obesity, suggesting inflammation reduction as a possibAug 21, 2026
HIF2 Activation in Cardiac Vasculature: A Novel Mechanistic Insight into Kawasaki Disease’s Cardiovascular ComplicationsThis study reveals how HIF2 activation drives coronary artery remodeling, inflammation, and thrombosis in a mouse model mirroring severe Kawasaki disease, uncovering new therapeutic targets for coronary complications.Aug 18, 2026